FILTER RESULTS
FILTER RESULTS
close.svg
Search Result for “manufacturer”

Showing 1 - 10 of 82

OPINION

Nose for business: Smell, sell, repeat in Thai laundry culture

Nonthawat Phakham, Published on 28/01/2026

» Have you ever felt confused buying fabric softener or detergent in Thailand? I have. Choosing these products is no longer just about scent. They now offer features like UV protection, night-dry and indoor-dry formulas, quick or expert wash options, fast-wash, anti–colour-transfer technology and multiple scent variations for each formula.

OPINION

China expands grip on wind energy

News, Ron Bousso, Published on 30/10/2025

» European governments seeking to expand offshore wind power are increasingly wary of Chinese companies' involvement. Countering China's dominance will be time-consuming and expensive, but political pressure and national security concerns may give the region little choice.

OPINION

Can Europe, China forge a climate connection?

Oped, Emmanuel Guerin & Bernice Lee, Published on 12/08/2025

» Earlier this year, the Chinese firm CATL, the world's largest battery-maker, unveiled an electric-vehicle (EV) battery capable of delivering a remarkable 520 kilometres (323 miles) of driving range after just five minutes of charging. The announcement came a month after BYD, China's leading EV manufacturer, launched its own ultra-fast charging system. In solar, too, the numbers are staggering: Chinese firms can now produce over 1,200 gigawatts of solar panels annually.

OPINION

Unite to solve neglected diseases

Oped, Muhammad Radzi Abu Hassan, Published on 29/04/2025

» The successful collaboration between the health ministries of Malaysia and Thailand, industry partners in Egypt and Malaysia, and the Drugs for Neglected Diseases initiative (DNDi) to bring a new hepatitis C antiviral drug -- ravidasvir -- to market in 2022 was an important milestone. For years, a 12-week course of treatment using sofosbuvir cost between $70,000 (2.34 million baht) and $80,000, putting it out of reach for many in the Global South. But ravidasvir -- a safe and effective alternative when combined with sofosbuvir -- costs far less, averaging less than $500 per course.

OPINION

Buyback binge

Oped, Postbag, Published on 28/03/2025

» Re: "Twenty listed firms seen likely to prep share buybacks", (Business, March 25). 

OPINION

Zelensky-Trump clash spurs rethink by US allies

News, Peter Apps, Published on 10/03/2025

» As they watched Ukrainian President Volodymyr Zelensky evicted from the White House last week after an unprecedented live televised quarrel with President Donald Trump and his Vice President JD Vance, some of America's closest allies began to swiftly reappraise decades of foreign and defence policy.

OPINION

Trump's tariffs will hit consumers and businesses

News, Nancy Qian, Published on 27/02/2025

» The opening salvos of US President Donald Trump's trade war have sent shockwaves around the world. Over the past weeks, his administration has broken with decades of free-trade orthodoxy, threatening to impose tariffs not only on strategic adversaries like China but also on longstanding allies like Canada and Mexico.

OPINION

Pollution puzzle

Postbag, Published on 07/02/2025

» Re: "Pulling a cure out of thin air", (Business, Feb 3). 

OPINION

Don't write the obituary of the lunch hour just yet

Oped, Jackie Mansky, Published on 26/11/2024

» Rewatching Modern Times the other day, I realised it's only a matter of time before something like the Billows Feeding Machine gets shilled on TikTok Shop.

OPINION

What Trump's win means for the climate

News, Gernot Wagner, Published on 11/11/2024

» Elections are supposed to clarify policy uncertainties, and on the economic front, Donald Trump's victory over Kamala Harris has done just that. All three major US stock indices and US Treasury yields jumped after Nov 5, reflecting expectations of both strong economic growth and soaring debt and inflation.